San Francisco Sentry Investment Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$78K Buy
1,369
+445
+48% +$26K 0.04% 309
2021
Q1
$56K Hold
924
0.02% 364
2020
Q4
$49K Hold
924
0.02% 359
2020
Q3
$43K Hold
924
0.02% 349
2020
Q2
$48K Sell
924
-24
-3% -$1.24K 0.03% 334
2020
Q1
$45K Hold
948
0.03% 296
2019
Q4
$48K Hold
948
0.02% 374
2019
Q3
$44K Buy
948
+24
+3% +$1.1K 0.02% 386
2019
Q2
$43K Sell
924
-409
-31% -$18.9K 0.02% 390
2019
Q1
$64K Buy
1,333
+1,109
+495% +$55.6K 0.03% 371
2018
Q4
$10K Sell
224
-133
-37% -$6.93K ﹤0.01% 562
2018
Q3
$19K Buy
357
+48
+16% +$2.46K 0.01% 511
2018
Q2
$15K Sell
309
-103
-25% -$5.84K 0.01% 532
2018
Q1
$26K Buy
412
+7
+2% +$480 0.01% 534
2017
Q4
$24K Buy
405
+301
+289% +$18.6K 0.01% 538
2017
Q3
$7K Buy
104
+14
+16% +$990 ﹤0.01% 691
2017
Q2
$7K Buy
+90
New +$6.79K ﹤0.01% 568

Other funds holding CAH

San Francisco Sentry Investment Group's CAH Position: Q2 2021 in Review

San Francisco Sentry Investment Group increased its Cardinal Health (CAH) stake by 48% in Q2 2021, buying an estimated $26K and bringing the position to 1,369 shares worth $78K. The position accounts for 0.04% of the portfolio, ranked #309.

San Francisco Sentry Investment Group first reported a position in CAH in Q2 2017 and has held it in 17 quarters since. 790 funds tracked by Wall St. Rank hold CAH as of Q2 2021.

  • San Francisco Sentry Investment Group held 1,369 shares of Cardinal Health worth $78K as of Q2 2021.
  • San Francisco Sentry Investment Group bought 445 Cardinal Health shares in Q2 2021, an estimated $26K.
  • Cardinal Health made up 0.04% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #309 holding.
  • San Francisco Sentry Investment Group first reported a position in Cardinal Health in Q2 2017 and has held it in 17 quarters since.
  • 790 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.